Chongqing Sansheng Industrial (002742) Stock Overview

Chongqing Sansheng Industrial Co.,Ltd. engages in the research and development, production, and sale of building materials and chemicals in China. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy and hydropower, etc.; and sulfuric acid for the production of fertilizers, chemicals, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises. It also provides pharmaceutical products comprising intermediates, such as procaine hydrochloride, cefoxitin acid intermediates, chloramphenicol intermediates, aztreonam intermediates, orlistat intermediates, etc., which are used in antibiotic drugs, anti-hepatitis C drugs, diabetes drugs, benzathine penicillin and cefoxitin, procaine penicillin and cosmetics, etc.; API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benoate, procaine hydrochloride, diphenhydramine hydrochloride, etc.; and preparation products, such as compound paracetamol diphenhydramine, cloperidine hydrochloride, clarithromycin sustained-release, diclofenac sodium enteric-coated, acetaminophen, famotidine tablets, etc., which are used in antipyretic and analgesic, antiviral, antibacterial, cough, allergy, local anesthesia, etc., as well as famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, and norfloxacin drugs for clinical medicines. The company was formerly known as Chongqing Sansheng Special Building Materials Co., Ltd. and changed its name to Chongqing Sansheng Industrial Co.,Ltd. in October 2016. The company was incorporated in 2002 and is based in Chongqing, China.